Dollar Amounts
USD (Millions)
Balance sheet data in USD (millions)
Doing some research...
Over 2021–2024 (figures in millions USD), The Cigna Group’s total assets were roughly stable overall: assets fell from 154,889 in 2021 to 143,932 in 2022 (‑7.1%), recovered to 152,761 in 2023 (+6.1%), and edged up to 155,881 in 2024 (+2.0%), ending essentially in line with 2021 (+0.6%). Total liabilities, however, moved differently — they dropped from 107,705 in 2021 to 98,981 in 2022 (‑8.1%) then rose to 106,410 in 2023 and jumped to 114,638 in 2024. As a result liabilities in 2024 exceeded the 2021 level by about 6.4%. Stockholders’ equity has weakened over the period: 47,112 in 2021 → 44,872 in 2022 (‑4.8%) → 46,223 in 2023 (+3.0%) → 41,033 in 2024 (‑11.2%), a net decline of about 12.9% versus 2021. That combination of higher liabilities and lower equity pushed up leverage materially — the liabilities/equity ratio climbed from ~2.29 in 2021 to ~2.79 in 2024 — which signals a higher balance-sheet risk profile. In an insurance/managed-care context this pattern can reflect stronger claim reserves, increased debt or financing (e.g., for transactions), or capital returns (buybacks/dividends) combined with underwriting or investment volatility; the zeroed 2025 line appears to be missing data rather than an economic change. Overall, assets are stable but rising liabilities and declining equity warrant monitoring of reserve adequacy, capital metrics and any financing or capital-return activities.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.